Latest News Feed
Plans to expand clinical program and uplist to the NASDAQ were also presented.
Research Presented at the American Society of Hematology Annual Meeting Highlights New Mechanisms to Overcome Immune Rejection
Plans to expand clinical program and uplist to the NASDAQ were also presented.
Research Presented at the American Society of Hematology Annual Meeting Highlights New Mechanisms to Overcome Immune Rejection